| Financier | Commitments |
|---|---|
| IDA Credit | 12.50 |
| Pandemic Emergency Financing Facility | 2.70 |
Uganda COVID-19 Response and Emergency Preparedness Project
Abstract*
The development objective of COVID-19 Response Project is to prevent, detect and respond to Coronavirus (COVID-19) and strengthen national systems for public health emergency preparedness in Uganda. This project has three components. 1) The first component, Case Detection, Confirmation, Contact Tracing, Recording, Reporting, aims to leverage investments made through the East Africa Public Health Laboratory Network Project (EAPHLNP) to enhance early... Show More
Development Objective
The objective of the Project is to prevent, detect and respond to COVID-19 and strengthen national systems for public health emergency preparedness in Uganda.
Key Details
Project Details
P174041
Active
Rogers Ayiko
Ministry of Finance, Planning and Economic Development
May 13, 2020
(as of board presentation)
July 15, 2020
August 31, 2020
US$ 15.20 million
Ministry of Health
2021
US$ 15.20 million
N/A
May 9, 2024
June 30, 2025
TBD
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 12.50 |
| IBRD + IDA Commitment | 12.50 |
| Lending Instrument | |
|---|---|
| Grant Amount | 2.70 |
| Total Project Cost** | 15.20 |
Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Jul 15, 2020 | IDA-67620 | Loan Commitment | 12,500,000.00 |
| Dec 2, 2022 | IDA-67620 | Loan Disb | 2,035,653.00 |
| Sep 5, 2023 | IDA-D9520 | Loan Disb | 6,550,000.00 |
| Dec 27, 2023 | IDA-D9520 | Loan Disb | 2,265,700.00 |
| Jun 7, 2023 | IDA-D9520 | Loan Disb | 2,046,000.00 |
| Jun 21, 2024 | IDA-D9520 | Loan Disb | 10,152,815.00 |
| May 3, 2024 | IDA-D9520 | Loan Disb | 2,142,500.00 |
| Jun 27, 2024 | IDA-D9520 | Loan Disb | 2,293,479.00 |
| Jul 13, 2022 | IDA-D9520 | Loan Disb | 10,500,000.00 |
| Jun 30, 2022 | IDA-D9520 | Loan Disb | 17,000,000.00 |
| Sep 29, 2022 | IDA-D9520 | Loan Disb | 49,150,800.00 |
| Sep 28, 2022 | IDA-D9520 | Loan Disb | 12,193,000.00 |
| Apr 18, 2023 | IDA-D9520 | Loan Disb | 5,125,000.00 |
| Mar 18, 2024 | IDA-67620 | Int Charges | 26,325.86 |
| Mar 18, 2024 | IDA-67620 | Int Charges | 26,325.86 |
| Mar 15, 2024 | IDA-67620 | Int Charges | 615.20 |
| Mar 15, 2024 | IDA-67620 | Int Charges | 615.20 |
| Feb 13, 2024 | IDA-67620 | Loan Disb | 1,138,650.00 |
| May 3, 2024 | IDA-67620 | Loan Disb | 1,360,431.20 |
| Jun 21, 2024 | IDA-67620 | Loan Disb | 188,000.02 |
| Sep 15, 2022 | IDA-67620 | Int Charges | 10,079.75 |
| Sep 15, 2022 | IDA-67620 | Int Charges | 10,079.75 |
| Sep 15, 2022 | IDA-67620 | Int Charges | 182.39 |
| Sep 15, 2022 | IDA-67620 | Int Charges | 182.39 |
| Mar 15, 2023 | IDA-67620 | Int Charges | 14,813.56 |
| Mar 15, 2023 | IDA-67620 | Int Charges | 14,813.56 |
| Mar 15, 2023 | IDA-67620 | Int Charges | 114.11 |
| Mar 15, 2023 | IDA-67620 | Int Charges | 114.11 |
| Apr 18, 2023 | IDA-67620 | Loan Disb | 720,000.00 |
| Jun 7, 2023 | IDA-67620 | Loan Disb | 1,226,900.00 |
| Sep 26, 2023 | IDA-67620 | Loan Disb | 385,380.00 |
| Sep 15, 2023 | IDA-67620 | Int Charges | 192.53 |
| Sep 15, 2023 | IDA-67620 | Int Charges | 192.53 |
| Sep 15, 2023 | IDA-67620 | Int Charges | 22,475.04 |
| Sep 15, 2023 | IDA-67620 | Int Charges | 22,475.04 |
| Mar 15, 2022 | IDA-67620 | Int Charges | 8,805.66 |
| Mar 15, 2022 | IDA-67620 | Int Charges | 8,805.66 |
| Oct 20, 2021 | IDA-67620 | Loan Disb | 2,988,010.00 |
| Dec 16, 2021 | IDA-D9520 | Loan Commitment | 164,300,000.00 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Monitoring and Evaluation | Moderately Satisfactory | 2024-09-19 |
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-09-19 |
| Progress towards achievement of PDO | Moderately Satisfactory | 2024-09-19 |
| Procurement | Moderately Satisfactory | 2024-09-19 |
| Project Management | Moderately Satisfactory | 2024-09-19 |
| Financial Management | Moderately Satisfactory | 2024-09-19 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Proportion of moderate and severe COVID-19 cases managed at designated regional and national referral hospital COVID treatment units in accordance with the national COVID-19 case management protocols Value 25.00 25.00 85.00 Date April 15, 2020 January 18, 2024 December 31, 2024 Comment Proportion of suspected COVID-19 cases having laboratory confirmation results within 48 hours of sample collection Value 50.00 99.50 95.00 Date April 20, 2020 January 18, 2024 December 31, 2024 Comment Percentage of population vaccinated, which is included in the priority population targets defined in national plan [disaggregated by sex] Value 0.00 59.00 25.00 Date August 31, 2021 January 18, 2024 December 31, 2024 Comment Proportion of national population, vaccinated through Bank financing, that are female Value 0.00 0.00 10.00 Date Comment Proportion of national population, vaccinated through Bank financing, that are male Value 0.00 0.00 10.00 Date Comment Total number of people in RHDs and refugee settlements benefiting from key Project interventions Value 0.00 1470787.00 3000000.00 Date August 31, 2021 January 18, 2024 December 31, 2024 Comment Total number of people in refugee settlements benefiting from key Project interventions Value 0.00 0.00 800000.00 Date Comment Total number of people in RHDs benefiting from key Project interventions Value 0.00 0.00 1500000.00 Date Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Proportion of Grievances captured in the Complaints Register for UCREPP that have been “CLOSED OUT” in accordance with GRM under the Project Value 0.00 100.00 85.00 Date April 14, 2020 January 18, 2024 December 31, 2024 Comment Number of laboratory tests done for suspected COVID-19 cases using approved testing technologies Value 194872.00 3669071.00 6000000.00 Date April 15, 2020 January 18, 2024 December 31, 2024 Comment Proportion of District Task Forces (DTFs) reviewing technical reports on continuity of Essential Health services in the past quarter Value 0.00 0.00 90.00 Date August 31, 2021 January 18, 2024 December 31, 2024 Comment Number of isolation facilities/intensive care units/high dependency units upgraded or remodeled countrywide Value 0.00 3.00 10.00 Date October 1, 2020 January 18, 2024 December 31, 2024 Comment Number of temporary health centers within refugee settlements with improved permanent infrastructure Value 0.00 0.00 3.00 Date Comment Number of vaccine-eligible refugees vaccinated through the Project Value 0.00 0.00 350000.00 Date Comment Number of laboratory tests done for COVID-19 suspected cases in RHDs Value 95000.00 95000.00 300000.00 Date Comment Number of isolation facilities/Intensive Care Units/High Dependency Units upgraded or remodeled in RHDs and refugee settlements Value 0.00 0.00 6.00 Date Comment Number of laboratory tests done for COVID-19 suspected cases in refugee settlements Value 40000.00 40000.00 155000.00 Date Comment Number of General Hospitals and health centers IVs refurbished in RHDs Value 0.00 0.00 3.00 Date Comment Number of people in refugee hosting districts vaccinated through the Project (excluding Kampala) Value 0.00 0.00 850000.00 Date Comment Number of emergency call and dispatch centers established and functional to address medical emergencies, GBV and psychosocial support Value 0.00 0.00 4.00 Date August 31, 2021 January 18, 2024 December 31, 2024 Comment Cumulative number of laboratories enrolled on ISO 15189 accreditation maintaining or achieving ISO 15189 accreditation Value 4.00 8.00 7.00 Date April 15, 2020 January 18, 2024 December 31, 2024 Comment Number of staff trained in critical, acute, and emergency medicine Value 35.00 411.00 500.00 Date October 28, 2020 January 18, 2024 December 31, 2024 Comment Number of ambulances procured and supplied countrywide under the project Value 0.00 40.00 40.00 Date August 31, 2021 January 18, 2024 December 31, 2024 Comment Number of staff trained in in critical, acute, and emergency medical services in refugee settlements Value 0.00 0.00 100.00 Date Comment Ambulances procured for refugee settlements and RHDs Value 0.00 0.00 15.00 Date Comment Proportion of staff trained in critical, acute, and emergency medical services that are female Value 0.00 0.00 45.00 Date Comment Number of targeted hospitals whose laboratory spaces have been remodeled/upgraded Value 0.00 0.00 2.00 Date April 15, 2020 January 18, 2024 December 31, 2024 Comment Number of health care workers and community stakeholders trained in managing GBV cases and psychosocial support countrywide Value 0.00 180.00 300.00 Date August 31, 2021 January 18, 2024 December 31, 2024 Comment Proportion of Village Health Teams in at least twenty (20) COVID-19 hotspot districts equipped to provide COVID-19 prevention, homebased care, and other essential health services Value 0.00 4.00 60.00 Date August 31, 2021 January 18, 2024 December 31, 2024 Comment Proportion of people travelling through twelve high priority PoEs screened for COVID-19 and other diseases of public health importance Value 10.00 144.00 95.00 Date April 20, 2020 January 18, 2024 December 31, 2024 Comment Units of whole blood issued to health facilities nationally in a year Value 253000.00 282931.00 260693.00 Date August 31, 2021 January 18, 2024 December 31, 2024 Comment Number of health care workers and community stakeholders trained in managing GBV cases and psychosocial support in RHDs Value 0.00 0.00 150.00 Date Comment Percentage of facilities that had over 95% availability of a basket of 41 commodities in the previous quarter Value 46.00 15.00 57.00 Date August 31, 2021 January 18, 2024 December 31, 2024 Comment Number of Health facilities and hospitals refurbished/renovated countrywide (Number) Value 0.00 0.00 10.00 Date August 31, 2021 January 18, 2024 December 31, 2024 Comment Number of vaccine doses procured by the Project Value 0.00 8967600.00 17000000.00 Date August 31, 2021 January 18, 2024 December 31, 2024 Comment